Compounds > technetium-tc-99m-medronate

technetium-tc-99m-medronate and Hyperoxaluria--Primary

technetium-tc-99m-medronate has been researched along with Hyperoxaluria--Primary* in 2 studies

Other Studies

2 other study(ies) available for technetium-tc-99m-medronate and Hyperoxaluria--Primary

ArticleYear
Evaluation of Oxalate Osteopathy Secondary to Hyperoxaluria With 18F-FDG PET/CT and 99mTc-HMDP Bone Scan.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:2

    We report a case of a 69-year-old woman with primary hyperoxaluria type I, who developed a severe hypercalcemia despite controlled secondary hyperparathyroidism. Bone scintigraphy showed diffuse increased uptake in axial and peripheral skeleton. F-FDG PET/CT showed countless striking hypermetabolic foci, interesting 2 types of lesions (joint calcifications and periosteal resorptions). Bone biopsy demonstrated inflammatory changes around many calcium oxalate crystals; hypercalcemia was then related to oxalate osteopathy. Immunotherapy with denosumab was thus initiated. Eighteen months later, a second PET/CT showed decreased F-FDG uptake, reflecting treatment efficacy on inflammatory reaction secondary to calcium oxalosis skeletal deposits.

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Hyperoxaluria, Primary; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Medronate

2019
Primary hyperoxaluria type 1. Bone scintigraphy, X-ray radiography, and gamma-ray quantitative CT.
    Clinical nuclear medicine, 1991, Volume: 16, Issue:9

    Topics: Adult; Bone and Bones; Humans; Hyperoxaluria, Primary; Male; Radiography; Technetium Tc 99m Medronate; Tomography, Emission-Computed

1991